ACCUiN KRAS ex2 Mutation Screening Kit is designed using polymerase chain reaction (PCR) technology, which utilizes specific primers to amplify the targeted region of human KRAS gene exon 2, followed by analysis of the mutation status through Sanger sequencing. ACCUiN KRAS ex2 Mutation Screening Kit detects mutations within the KRAS exon 2, specifically covering codon 1 to 37. ACCUiN KRAS ex2 Mutation Screening Kit includes KRAS ex2 quality control (KRAS ex2 QC) to monitor the accuracy of the testing workflow and results. ACCUiN KRAS ex2 Mutation Screening Kit accommodates at least 48 testing reactions.